Neuronetics STIM
NASDAQ STIM
$3.07 -0.07 (-2.21%)
At close: Aug 20, 2026 · 1:18 PM UTC

Neuronetics (STIM) Net Equity Issued and Repurchased (2021 - 2026)

Neuronetics (STIM) posted quarterly Net Equity Issued and Repurchased of -$13000.0 for Q4 2025, down 100.16% quarter-over-quarter from $8.3 million in Q3 2025.

Neuronetics (STIM) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

Neuronetics (STIM) has reported Net Equity Issued and Repurchased for 2 consecutive years, with -$13000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to -$13000.0; the TTM figure through Dec 2025 stood at $29.0 million (changed N/A YoY), while the FY2025 annual figure was $8.3 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased retreated to -$13000.0 in Q4 2025 per STIM's latest filing, from $8.3 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $81.0 million in Q1 2021 and bottomed at -$13000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn -
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn -
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn -
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn -
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn -
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn -
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn -
10 Neuronetics 224.51 Mn 205.07 Mn 21.22 Mn 8.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 8.00 Mn
Jun 30, 2026 8.00 Mn
Dec 31, 2025 -13,000.00
Dec 31, 2025 -13,000.00
Sep 30, 2025 8.30 Mn
Sep 30, 2025 8.30 Mn
Mar 31, 2025 20.70 Mn
Mar 31, 2025 20.70 Mn
Mar 31, 2021 80.97 Mn
Mar 31, 2021 80.97 Mn